News

News

TSO3 Sets Second Quarter 2016 Conference Call for Wednesday, August 3, 2016 at 10:30 a.m. EDT

Québec City, July 20, 2016 – TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, August 3, 2016 at 10:30 a.m. Eastern Daylight time to discuss its financial results for the second quarter ended June 30, 2016. Financial results will be issued in a press release prior to the call.

Read more

News

TSO3 Responds to U.S. Regulators on Extended Claims and Provides Operations Update

Québec City, June 1, 2016 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has responded to a previously announced request for additional information by the U.S. Food and Drug Administration (the FDA) and that it has substantially completed its improvements to its manufacturing facility in Québec.

Read more

News

Canadian Journal of Infection Control to Publish Paper on TSO3’s STERIZONE® VP4 Sterilizer

Québec City, May 18, 2016 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that a peer-reviewed paper describing the Company’s STERIZONE® VP4 Sterilizer has been accepted for publication in the Canadian Journal of Infection Control (CJIC). The paper entitled “The First Dual-Sterilant Low-Temperature Sterilization System” will appear in an upcoming issue of the publication.

Read more